COVID-19 in Patients with CKD in New York City.

ABSTRACT:

Background

COVID-19 has affected millions of people, and several chronic medical conditions appear to increase the risk of severe COVID-19. However, our understanding of COVID-19 outcomes in patients with CKD remains limited.

Methods

This was a retrospective cohort study of patients with and without CKD consecutively admitted with COVID-19 to three affiliated hospitals in New York City. Pre-COVID-19 CKD diagnoses were identified by billing codes and verified by manual chart review. In-hospital mortality was compared between patients with and without underlying CKD. Logistic regression was used to adjust this analysis for confounders and to identify patient characteristics associated with mortality.

Results

We identified 280 patients with CKD, and 4098 patients without

SUBMITTER: Akchurin O 

PROVIDER: S-EPMC7901833 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature